A Phase I Trial of Ad.hIFN-β Gene Therapy for Glioma
E. Antonio Chiocca(Center for Cancer Research), David H. Kirn(Alameda Applied Sciences Corporation (United States)), Kevin O. Lillehei(University of Colorado Health), Cheryl A. Palmer(University of Alabama at Birmingham), Allan J. Hamilton(Arizona Science Center), Steven Rosenfeld(Columbia University), Katie Smith(Biogen (United States)), B. K. DeMasters(University of Colorado Health), Kevin Judy(Hospital of the University of Pennsylvania), Byron McKinney(Biogen (United States))
Cited by 118
Related Papers
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles
|Science Advances|2018|614
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
|Journal of Translational Medicine|2018|540